Global Authority on Sustainable Business Growth. Bestselling Author, Reimagining Capitalism in a World on Fire. Professor, Harvard Business School
Microbiologist, biochemist, and geneticist, winner of the Chemistry Nobel Prize in 2020. Keynote speaker Emmanuelle Charpentier has spent many years of her life researching human pathogens and has earned several awards thanks to her excellent work. Organizations book Emmanuelle Charpentier for her knowledge of the revolutionary CRISPR-Cas9 gene editing technology and her views into the future of science and genetics.
Want to book Emmanuelle Charpentier as a speaker for your event? Please provide the info below and we’ll get in touch within 24h:
Keynote speaker Emmanuelle Charpentier is a French microbiologist, a biochemist, as well as a geneticist. Furthermore, she was the winner of the Chemistry Nobel Prize in 2020, together with Jennifer Doudna. They also co-won the 2020 Wolf Prize in Medicine. These two remarkable women have successfully developed new genome editing techniques.
Following her studies in France, Emmanuelle began an intense scientific career in both Europe and the US. Emmanuelle has spent the majority of her professional career studying disease basic processes. Her research has put a strong emphasis on infections caused by Gram-positive bacterial pathogens, including staphylococci, Listeria, and streptococci.
Emmanuelle has conducted plenty of lab work on the CRISPR-Cas9 acquired immune system in various bacteria. Her research laid the groundwork for the creation of a unique, extremely flexible, and specialized editing and engineering technique for genomes. The CRISPR-Cas technology is transforming life science studies. CRISPR-Cas has created a whole new potential for biotechnologies and biomedical gene therapies, with far-reaching implications for society and mankind. CRISPR-Cas biology and engineering continue to advance at an incredible rate, with fascinating new findings surfacing frequently.
Emmanuelle Charpentier is a speaker who has earned several awards, honors, and doctorate degrees in Asia, North America, and Europe. She and her team’s contributions to the so-called CRISPR-Cas9 discovery led to them receiving numerous awards. Some of Charpentier’s awards include the Breakthrough Prize in Life Sciences, the Gruber Foundation International Prize in Genetic, as well as the Leibniz Prize
Currently, she serves as an elected member of several scientific academies, both internationally and nationally. Emmanuelle is the co-owner and co-inventor of the CRISPR-Cas9 technology’s core intellectual property.
She also co-founded ERS Genomics and CRISPR Therapeutics, together with Shaun Foy and Rodger Novak. Their goal was to develop the CRISPR-Cas technology for genome engineering for use in biotechnological and medicinal applications.
CRISPR/Cas9 allows scientists to easily alter DNA sequences and modify gene functions. Its many potential applications include correcting genetic defects, treating and preventing the spread of diseases. As a powerful tool for genome editing, its promise also raises ethical concerns.
|Basic Data Protection Information
|AURUM SPEAKERS BUREAU S.L.
|Doctor Ullés 2, 3º 1ª, CP 08224, TERRASSA (Barcelona)
|We will use your data to respond to your requests and deliver our services to you.
|We will only send you marketing correspondence if you have given your prior consent, which you can do by ticking the box for that purpose.
|We will only process your data if you have given your prior consent, which you can do by ticking the box for that purpose.
|Generally, only our members of staff who have been duly authorised may access the data that you have provided.
|You have the right to know what information we hold about you, to rectify it and to erase it, as explained in the additional information available on our website.